Inhaled nitric oxide (NO) is a selective pulmonary vasodilator that significantly reduces the neonatal morbidity and mortality associated with pulmonary hypertension (1,2). Given the cost and need for ...

Endothelins (ET) have opposite vascular effects mediated through different receptors: ET A receptors mediating vasoconstriction and ET B receptors mediating vasoconstriction as well as vasodilation.

PULMONARY hypertension is a serious and relatively frequent complication of the ostiumsecundum type of defect of the atrial septum. 1–4 It increases the symptoms and disability of cardio-respiratory ...

In the last several years, there have been numerous advancements in the field of pulmonary hypertension as a whole, but there have been few changes in the management of children with pulmonary ...

Pulmonary Circulation, Vol. 3, No. 4 (December 2013), pp. 898-907 (10 pages) AbstractPulmonary hypertension (PH) is an incurable disease that often leads to right ventricular hypertrophy and right ...

Patients with chronic obstructive pulmonary disease (COPD) may develop pulmonary hypertension because of pulmonary vasoconstriction secondary to alveolar hypoxia with additional vasoconstriction ...

https://doi.org/10.4103/2045-8932.87295 • https://www.jstor.org/stable/10.4103/2045-8932.87295 Copy URL AbstractIn this perspective, we review published data which ...